Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024

SELL
$5.8 - $8.98 $41,934 - $64,925
-7,230 Closed
0 $0
Q3 2022

Aug 14, 2024

BUY
$7.55 - $11.25 $35,741 - $53,257
4,734 Added 189.66%
7,230 $60.8 Million
Q2 2022

Aug 14, 2024

BUY
$6.8 - $14.23 $16,972 - $35,518
2,496 New
2,496 $18.9 Million
Q3 2020

Aug 30, 2024

SELL
$11.59 - $14.93 $21,209 - $27,321
-1,830 Closed
0 $0
Q4 2019

Aug 30, 2024

BUY
$13.91 - $21.48 $25,455 - $39,308
1,830 New
1,830 $36.6 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.